US private equity group Horizon Capital has made an undisclosed investment in marketing technology company Viseven, which serves the pharma and life sciences sectors.
In the intricate landscape of pharmaceutical advertising, treading the fine line between compliance and legal language regulations is comparable to a delicate tightrope walk.
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K